What you'll find here at MDLinx Rheumatology: The top rheumatology clinical articles of the day, plus MDLinx exclusive content
Your Unread Messages in Rheumatology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Hypovitaminosis D common in SLE
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Rheumatologists
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1
Use of Lipid-lowering Agents in Rheumatoid Arthritis: A Population-based Cohort Study
The Journal of Rheumatology, May 11, 2013
Clinical Article
Exclusive Author Commentary
2 The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA Annals of Rheumatic Diseases, May 11, 2013 Clinical Article
3 Treatment strategies for early rheumatoid arthritis Current Opinion in Rheumatology, May 11, 2013 Clinical Article
4 Kinase inhibitors: A new tool for the treatment of Rheumatoid Arthritis Clinical Immunology, May 11, 2013 Clinical Article
5 Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study Annals of Rheumatic Diseases, May 11, 2013 Clinical Article
6 Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis- A register-based study Seminars in Arthritis and Rheumatism, May 11, 2013 Clinical Article
7 Rheumatoid arthritis in the elderly: recent advances in understanding the pathogenesis, risk factors, comorbidities and risk-benefit of treatments Aging Health, May 11, 2013 Review Article
8 Obesity among women may increase the risk of arthritis: observations from the Canadian Community Health Survey, 2007-2008 Rheumatology International, May 11, 2013 Clinical Article
9 New methods for determining comparative effectiveness in rheumatoid arthritis Current Opinion in Rheumatology, May 11, 2013 Clinical Article
10 Long-term treatment of rheumatoid arthritis with adalimumab Full Text Open Access Rheumatology: Research and Reviews, May 11, 2013 Clinical Article
11 Induced abortions in women with rheumatoid arthritis on methotrexate Arthritis Care & Research , May 11, 2013 Clinical Article
12 Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritis Current Opinion in Rheumatology, May 11, 2013 Clinical Article
13 Biologic therapies and systemic bone loss in Rheumatoid Arthritis Autoimmunity Reviews, May 11, 2013 Clinical Article
14 Assessing subclinical synovitis in rheumatoid arthritis Arthritis & Rheumatism, May 11, 2013 Clinical Article
15 Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy Arthritis Research & Therapy, May 11, 2013 Review Article
16 Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program The Journal of Rheumatology, April 27, 2013 Clinical Article
17 The impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis (RA) vs. non-RA subjects: Results from a population-based study Arthritis Care & Research , April 27, 2013 Clinical Article
18 Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis Annals of Rheumatic Diseases, April 27, 2013 Evidence Based Medicine Review Article Clinical Article
19 Clinical Response Within 12 Weeks as a Predictor of Future Low Disease Activity in Patients with Early RA: Results from the TEAR Trial The Journal of Rheumatology, April 27, 2013 Clinical Article
20 Longterm Effects of Rituximab on B Cell Counts and Autoantibody Production in Rheumatoid Arthritis: Use of High-sensitivity Flow Cytometry for More Sensitive Assessment of B Cell Depletion The Journal of Rheumatology, April 27, 2013 Clinical Article
21 Adalimumab: 8 years of experience in rheumatoid arthritis International Journal of Clinical Rheumatology, April 27, 2013 Clinical Article
22 Possible rheumatoid arthritis subtypes in terms of rheumatoid factor, depression, diagnostic delay and emotional expression: an exploratory case-control study Arthritis Research & Therapy, April 27, 2013 Clinical Article
23 Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies Annals of Rheumatic Diseases, April 27, 2013 Clinical Article
24 IL-32 with potential insights into rheumatoid arthritis Clinical Immunology, April 27, 2013 Review Article
25 The type I IFN signature as a biomarker of preclinical rheumatoid arthritis Annals of Rheumatic Diseases, April 27, 2013 Clinical Article
26 Effects of smoking on the clinical phenotype and response to treatment in rheumatoid arthritis International Journal of Clinical Rheumatology, April 27, 2013 Clinical Article
27 EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis Annals of Rheumatic Diseases, April 14, 2013 Clinical Article
28 Safety of Rituximab in Combination with Other Biologic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: An Open-label Study The Journal of Rheumatology, April 14, 2013 Clinical Article
29 Association between testosterone levels and risk of future rheumatoid arthritis in men: a population-based case-control study Annals of Rheumatic Diseases, April 14, 2013 Clinical Article
30 Long-term therapeutic effects and safety of tacrolimus added to methotrexate in patients with rheumatoid arthritis Rheumatology International, April 14, 2013 Clinical Article
31 Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial Annals of Rheumatic Diseases, April 14, 2013 Clinical Article
32 Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study The Journal of Rheumatology, April 14, 2013 Clinical Article
33 Agreement between the das-crp assessed with 3 and 4 variables in patients with rheumatoid arthritis treated with biological agents in the daily clinic The Journal of Rheumatology, April 14, 2013 Clinical Article
34 Epidermal growth factor receptor (EGFR) as a therapeutic target in rheumatoid arthritis Clinical Rheumatology, April 14, 2013 Clinical Article
35 Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study Annals of Rheumatic Diseases, April 14, 2013 Clinical Article
36 Cardiovascular Events Are Not Associated with MTHFR Polymorphisms, But Are Associated with Methotrexate Use and Traditional Risk Factors in US Veterans with Rheumatoid Arthritis The Journal of Rheumatology, April 14, 2013 Clinical Article
37 Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data Modern Rheumatology, April 14, 2013 Clinical Article
38 Metabolic profiling predicts response to anti-TNF therapy in patients with rheumatoid arthritis Arthritis & Rheumatism, April 14, 2013
39 Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial The Lancet, March 31, 2013 Clinical Article
40 The diagnostic utility of matrix metalloproteinase-3 and high-sensitivity C-reactive protein for predicting rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-negative patients with recent-onset undifferentiated arthritis Rheumatology International, March 31, 2013 Clinical Article
41 Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over Osteoporosis International, March 31, 2013 Clinical Article
42 Anti-citrullinated protein antibodies (ACPA) in unaffected first degree relatives of rheumatoid arthritis patients Arthritis & Rheumatism, March 31, 2013
43 Detection, scoring and volume assessment of bone erosions by ultrasonography in rheumatoid arthritis: comparison with CT Annals of Rheumatic Diseases, March 31, 2013 Clinical Article
44 Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study Annals of Rheumatic Diseases, March 31, 2013 Clinical Article
45 Evaluation of serum biomarkers associated with radiographic progression in methotrexate-naive rheumatoid arthritis patients treated with methotrexate or golimumab The Journal of Rheumatology, March 31, 2013 Clinical Article
46 HLA-G may predict the disease course in patients with early rheumatoid arthritis Human Immunology, March 31, 2013 Review Article Clinical Article
47 Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial Annals of Rheumatic Diseases, March 31, 2013 Clinical Article
48 Adalimumab: long-term safety in 23458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohns disease Annals of Rheumatic Diseases, March 17, 2013 Clinical Article
49 Changes in lipoproteins associated with treatment with methotrexate or combination therapy in early rheumatoid arthritis: Results from the TEAR trial Arthritis & Rheumatism, March 17, 2013 Clinical Article
50 Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis Annals of Rheumatic Diseases, March 17, 2013 Clinical Article
51 Subcutaneous abatacept for the treatment of rheumatoid arthritis Rheumatology, March 17, 2013 Clinical Article
52 Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial Annals of Rheumatic Diseases, March 17, 2013 Clinical Article
53 Periarticular Bone Gain at Proximal Interphalangeal Joints and Changes in Bone Turnover Markers in Response to Tumor Necrosis Factor Inhibitors in Rheumatoid and Psoriatic Arthritis The Journal of Rheumatology, March 17, 2013 Clinical Article
54 Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses Health Study Annals of Rheumatic Diseases, March 17, 2013 Clinical Article
55 Parental history of lupus and rheumatoid arthritis and risk in offspring in a nationwide cohort study: does sex matter Annals of Rheumatic Diseases, March 17, 2013 Clinical Article
56 Risk of rheumatoid arthritis development in patients with unclassified arthritis according to the 2010 ACR/EULAR criteria for rheumatoid arthritis Rheumatology, March 17, 2013 Clinical Article
In a study involving 74 patients with juvenile idiopathic arthritis (JIA), 26 patients had detectable anti-citrullinated protein antibodies (ACPA). The ACPA titers correlated with disease progression at baseline and after a median follow-up of 11.5 months. In addition to predicting disease severity and progression, the authors concluded that ACPA were superior to IgM-RF in diagnosing JIA.
Read the article summaryIn a study involving 208 patients with SLE followed for 12 years, 42 deaths occurred, 48% of which were considered to be cardiovascular mortalities. Age, increased cystatin C levels, and arterial disease were predictive of all-cause mortality. Cigarette smoking and increased sVCAM-1, hsCRP, abeta2GP1, and aPL antibody levels were predictive of cardiovascular mortality.
Read the article summaryIn a study conducted at the University of Geneva involving 118 patients with rheumatoid arthritis, but without cardiovascular disease at baseline, the 10-year Framingham cardiovascular risk score (FRS) was improved with the inclusion of the anti-apoA-1 antibody titer. The median follow-up was 9 years and the incidence of cardiovascular disease was 16%. Other biomarkers, including the NT-proBNP, oxLDL, CRP, and RF levels and the anti-citrullinated peptide antibody titer, did not improve the FRS.
Read the article summaryIndexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close